Countrywise results of total hip replacement An analysis of 438,733 hips based on the Nordic Arthroplasty Register Association database by Makela, Keijo T. et al.
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=iort20
Download by: [University of Helsinki] Date: 16 June 2016, At: 06:15
Acta Orthopaedica
ISSN: 1745-3674 (Print) 1745-3682 (Online) Journal homepage: http://www.tandfonline.com/loi/iort20
Countrywise results of total hip replacement
Keijo T Mäkelä, Markus Matilainen, Pekka Pulkkinen, Anne M Fenstad, Leif
I Havelin, Lars Engesaeter, Ove Furnes, Søren Overgaard, Alma B Pedersen,
Johan Kärrholm, Henrik Malchau, Göran Garellick, Jonas Ranstam & Antti
Eskelinen
To cite this article: Keijo T Mäkelä, Markus Matilainen, Pekka Pulkkinen, Anne M Fenstad,
Leif I Havelin, Lars Engesaeter, Ove Furnes, Søren Overgaard, Alma B Pedersen, Johan
Kärrholm, Henrik Malchau, Göran Garellick, Jonas Ranstam & Antti Eskelinen (2014)
Countrywise results of total hip replacement, Acta Orthopaedica, 85:2, 107-116, DOI:
10.3109/17453674.2014.893498
To link to this article:  http://dx.doi.org/10.3109/17453674.2014.893498
Copyright: © Nordic Orthopaedic Federation View supplementary material 
Published online: 20 Mar 2014. Submit your article to this journal 
Article views: 710 View related articles 
View Crossmark data Citing articles: 2 View citing articles 
Acta Orthopaedica 2014; 85 (2): 107–116 107
Countrywise results of total hip replacement
An analysis of 438,733 hips based on the Nordic Arthroplasty Register Asso-
ciation database
Keijo T Mäkelä1, Markus Matilainen2, Pekka Pulkkinen3, Anne M Fenstad4, Leif I Havelin4,5,   
Lars Engesaeter4,5, Ove Furnes4,5, Søren Overgaard6,8, Alma B Pedersen6,7, Johan Kärrholm9, 
Henrik Malchau9, Göran Garellick9, Jonas Ranstam10, and Antti Eskelinen11
1Department of Orthopaedics and Traumatology, Turku University Hospital; 2Department of Biostatistics, Turku University, Turku; 3Hjelt Institute, Helsinki 
University, Helsinki, Finland; 4The Norwegian Arthroplasty Register, Department of Orthopaedic Surgery, Haukeland University Hospita; 5Department of 
Clinical Medicine, University of Bergen, Bergen, Norway; 6The Danish Hip Arthroplasty Register, Center for Clinical Databases, Department of Clinical 
Epidemiology; 7Competence Center for Clinical Epidemiology and Biostatistics, North, Department of Clinical Epidemiology, Aarhus University Hospital, 
Aarhus; 8Department of Orthopaedic Surgery and Traumatology and Clinical Institute, Odense University Hospital, Odense, Denmark; 9The Swedish Hip 
Arthroplasty Register, Department of Orthopaedics, Institute of Surgical Sciences, Sahlgrenska University Hospital, University of Gothenburg, Mölndal, 
Sweden and Orthopaedic Department, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA; 10Swedish National Competence 
Center Musculoskeletal Disorders, Skåne University Hospital, Lund, Sweden; 11The Coxa Hospital for Joint Replacement, Tampere, Finland.
Correspondence: keijo.makela@fimnet.fi
Submitted 13-09-10. Accepted 14-01-03
Open Access - This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, 
distribution, and reproduction in any medium, provided the source is credited.
DOI 10.3109/17453674.2014.893498
Background and purpose   An earlier Nordic Arthroplasty Regis-
ter Association (NARA) report on 280,201 total hip replacements 
(THRs) based on data from 1995–2006, from Sweden, Norway, 
and Denmark, was published in 2009. The present study assessed 
THR survival according to country, based on the NARA database 
with the Finnish data included. 
Material and methods   438,733 THRs performed during the 
period 1995–2011 in Sweden, Denmark, Norway, and Finland 
were included. Kaplan-Meier survival analysis was used to calcu-
late survival probabilities with 95% confidence interval (CI). Cox 
multiple regression, with adjustment for age, sex, and diagnosis, 
was used to analyze implant survival with revision for any reason 
as endpoint.
Results   The 15-year survival, with any revision as an endpoint, 
for all THRs was 86% (CI: 85.7–86.9) in Denmark, 88% (CI: 
87.6–88.3) in Sweden, 87% (CI: 86.4–87.4) in Norway, and 84% 
(CI: 82.9–84.1) in Finland. Revision risk for all THRs was less 
in Sweden than in the 3 other countries during the first 5 years. 
However, revision risk for uncemented THR was less in Denmark 
than in Sweden during the sixth (HR = 0.53, CI: 0.34–0.82), sev-
enth (HR = 0.60, CI: 0.37–0.97), and ninth (HR = 0.59, CI: 0.36–
0.98) year of follow-up.
Interpretation   The differences in THR survival rates were con-
siderable, with inferior results in Finland. Brand-level compari-
son of THRs in Nordic countries will be required.

There is a long tradition of arthroplasty registries in the Nordic 
countries. The Swedish Hip Arthroplasty Register was estab-
lished in 1979 (Malchau et al. 2002), the Finnish Arthroplasty 
Register in 1980 (Paavolainen et al. 1991, Puolakka et al. 
2001), the Norwegian Arthroplasty Register in 1987 (Havelin 
et al. 2000), and the Danish Hip Arthroplasty Register in 1995 
(Lucht 2000). The Nordic Arthroplasty Register Association 
(NARA) was established in 2007 by Sweden, Norway, and 
Denmark to improve the quality of total hip and knee arthro-
plasty through registry-based research collaboration. Finland 
became a full member of NARA in 2010. 
A multinational implant registry is needed in order to detect 
inferior implants as early as possible. To date, the NARA data-
base is the most developed multinational database worldwide. 
However, NARA results are not available on the internet or in 
yearbooks; the information is shared using scientific papers. 
Monitoring and comparison of country-specific results is a 
step forward in the development of NARA activity. An ear-
lier NARA report on 280,201 THRs, based on data from the 
period 1995–2006 from Sweden, Norway, and Denmark, was 
published in 2009 (Havelin et al. 2009). In the present paper, 
we have updated the survival results for THR in the Nordic 
countries with the Finnish data included and we consider and 
discuss the differences found.
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Material and methods
Sources of data
The registries of Sweden, Denmark, Norway, and Finland 
participated. From 1995, all 4 registries have used individual-
based registration of operations and patients. The data there-
fore include THRs performed during the period 1995–2011. 
A minimal NARA dataset was created to contain data that all 
registries could deliver (Havelin et al. 2009). The degree of 
coverage and completeness of the Nordic registries is high 
(Arthursson et al. 2005, Espehaug et al. 2006, DHAR 2011, 
SHAR 2011, Peltola 2013).
Selection and transformation of the respective datasets and 
de-identification of the patients, including deletion of the 
national civil registration numbers, was performed within 
each national registry. Anonymous data were then merged into 
a common database. 
Ethical approval of the study was obtained through each 
national registry. 
Inclusion and exclusion criteria
Until 2011, 536,962 primary hip replacements had been 
included in the NARA database. A flow chart of the exclu-
sion of hip replacements according to our study criteria is pre-
sented in Figure 1. If a patient had replacement of both hips in 
the database, only the first one was included due to potential 
bias from bilaterality (Ranstam et al. 2011). We also wanted 
to make sure that the potential errors in recording of laterality 
did not bias the analyses. 88,723 hips were excluded due to 
the bilaterality criteria. 38 revision operations were excluded. 
The 3 patients over 100 years old were excluded from the 
study due to suspected coding errors. 2,312 hip replacements 
were excluded because information on the type of fixation was 
not available. 7,130 hip resurfacings were excluded from the 
analyses. In addition, 3 patients were excluded due to having 
“bilateral” as an operative side. 20 hips were excluded because 
the laterality of the first operation was not mentioned. 
Altogether, 438,733 hip replacements were included: 
278,315 cemented, 101,940 uncemented, 36,322 hybrid 
(uncemented cup, cemented stem), and 22,156 reverse hybrid 
(cemented cup, uncemented stem).
Statistics
We used Kaplan-Meier analysis to study prosthetic survival 
at 10 and 15 years until there were at least 100 THRs left at 
risk. Patients were censored at death or December 31, 2011, 
whichever came first. Outcome was any revision, defined as 
removal or exchange of at least 1 of the components. Liner 
exchanges were recorded under the same label as cup revisions 
in the NARA hip database. We used a Cox multiple regression 
model to assess survival and hazard ratio (HR) with any revi-
sion as endpoint, with confidence interval CI, and with adjust-
ment for age, sex, and diagnosis. The stratification was made 
with the age groups and diagnoses given in Table 1. Adjust-
ments were made by stratifying with age groups, diagnosis, 
and sex for data given in Tables 4 and 5. Adjustments were 
made by stratifying with diagnosis for data given in Tables 6 
and 7 (subgroup analyses). Sweden was chosen as the refer-
ence country, because the Swedish Hip Arthroplasty Register 
had the highest number of THRs recorded. 
Because the factor country analysis did not fulfill the pro-
portional hazards assumption, the follow-up period was split 
into 1-year time periods in the analysis of all THRs, cemented 
THR, and uncemented THR. Also, the first year was divided 
into 2 periods to assess early postoperative revisions.
The follow-up period for hybrid and reverse hybrid THRs 
was split into 3-year time periods because of the relatively low 
number of cases. The first year was divided into 2 periods, < 6 
months and 6–24 months, followed by the third period from 2 
to 5 years and so on. 
We performed survival analyses separately for subgroups 
of female and male patients aged < 60 years and ≥ 60 years 
with cemented or uncemented THRs. Because countrywise 
subgroup analyses did not fulfill the proportional hazards 
assumption either, the follow-up period for subgroup analy-
sis was split into periods in the same way as for hybrids and 
reverse hybrids, as described above. 
We adjusted for diagnosis in subgroup analyses for female 
and male patients aged < 60 years and ≥ 60 years. The Wald 
test was used to calculate the p-values for data obtained from 
the Cox multiple regression analyses. Differences between 
groups were considered to be statistically significant if the 
p-values were < 0.05 in a 2-tailed test.
We performed time-trend analyses to assess changes in the 
revision rate over a 17-year period (1995 through 2011). The 
patients were divided into 3 groups according to the year of 
primary surgery: 1995–1999, 2000–2005, and 2006–2011. 
The first period, from 1995 through 1999, was used as the 
reference period. Kaplan-Meier survival analysis with 95% 
Figure 1. Flow chart of exclusion of hip replacements according to the 
study criteria.  
 
536,962
hip replacements
Not the first operation
of the patient:
88,761 excluded
Patient older than 100:
3 excluded
Hip resurfacings and THRs
with missing fixation type:
9,442 excluded
Operations with
unknown laterality:
23 excluded
448,201
hip replacements
448,198
hip replacements
438,756 THRs
438,733 THRs
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CIs was used to compare cumulative implant survival between 
subgroups of patients (i.e. patients operated during the 3 time 
periods).
Results
438,733 THRs fulfilled the inclusion criteria for the study 
(180,839 in Sweden, 92,078 in Denmark, 86,076 in Norway, 
and 79,740 in Finland). Data concerning demographics, 
fixation technique, surgical approach, cause of revision, and 
procedure performed at revision are presented for each coun-
try in Table 1 and in Figures 2, 3, and 4. The proportion of 
male patients was 42% in Denmark, 40% in Sweden, 32% in 
Norway, and 41% in Finland. The proportion of patients aged 
75 years and over was 32% in Denmark, 35% in Sweden, 35% 
in Norway, and 26% in Finland. Hip fracture as an indication 
for THR was more common in Denmark (14%), in Sweden 
(12%), and in Norway (12%) than in Finland (3.7%). Unce-
mented fixation was common in Denmark (40%) and in Fin-
land (48%), but rare in Sweden (7.5%) and in Norway (15%). 
Aseptic loosening was the most common cause of revision in 
all countries. Cup/liner revision was the most common proce-
dure performed at revision in Denmark (44%), Sweden (32%), 
and Norway (37%). For Finland, the corresponding data were 
not available.
Kaplan-Meier 10- and 15-year survival data are presented 
by country for all THRs, cemented THR, uncemented THR, 
hybrid THR, and reverse hybrid THR in Table 2 and Figures 
5–9. The 15-year survival for all THRs was 86.3% (CI: 85.7–
86.9) in Denmark, 88.0% (CI: 87.6–88.3) in Sweden, 86.9% 
in Norway (CI: 86.4–87.4), and 83.5% (CI: 82.9–84.1) in Fin-
land.
Kaplan-Meier 10- and 15-year survival data for subgroup 
analyses performed separately for female and male patients 
aged < 60 years and ≥ 60 years are presented for cemented 
Table 1. Demographic data, and data concerning fixation technique, surgical 
approach, cause of revision, and procedure performed at revision for each country
 Denmark Sweden Norway Finland
No. of THRs 92,078 180,839 86,076 79,740
Follow-up time (years), mean 5.9 6.7 6.4 6.6
  (range) (0–17) (0–17) (0–17) (0–17)
Male sex, % 41.9 40.0 31.8 41.1
Age groups, %
 < 55 10.8 9.0 10.7 11.9
 55–64 22.7 21.8 20.6 24.1
 65–74 34.8 34.4 34.3 37.8
 ≥ 75 31.6 34.8 34.5 26.3
Diagnosis, %
 Primary osteoarthritis 76.4 78.7 73.0 82.4
 Hip fracture 13.9 12.3 11.7   3.7
 Nontraumatic femoral head necrosis   2.6   3.1   1.6   1.1
 Inflammatory arthritis   1.6   2.3   2.4   4.6
 Pediatric hip disease   3.1   1.8   9.0   1.2
 Other   2.3   1.9   2.3   7.0
Fixation, %
 Cemented 36.9 84.1 70.8 39.3
 Uncemented 40.3   7.5 15.3 47.8
 Hybrid 21.9   3.1   3.3   9.6
 Reverse hybrid   0.9   5.3 10.6   3.4
Approach, %
 Posterior 92.2 57.2 24.6 NA
Cause of revision, %
 Aseptic loosening 36.2 53.3 48.8 48.5
 Deep infection 15.4 14.1 15.6 6.7
 Periprosthetic femoral fracture   8.2   8.2   4.0 7.7
 Dislocation 28.5 19.6 20.1 19.3
 Pain only   3.6   0.6   3.0 NA
 Other   8.1   4.3   8.7 17.8
Procedure at revision, %, 
 Total revision 16.7 31.5 20.6 NA
 Only stem revised 22.3 22.5 23.9 NA
 Only cup or liner revised 44.2 32.1 37.0 NA
 Extraction of the prosthesis   8.4   5.8   7.8 NA
 Other   8.5   8.2 10.7 NA
NA: not available.
Figure 2. Sex distribution in total hip replacement in 
4 Nordic countries. 
Figure 3. Distribution of age groups in total hip 
replacement in 4 Nordic countries.
Figure 4. Distribution of type of fixation in total hip 
replacement in 4 Nordic countries.
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 H
els
ink
i] 
at 
06
:15
 16
 Ju
ne
 20
16
 
110 Acta Orthopaedica 2014; 85 (2): 107–116
and uncemented THR by country in Table 3. The 15-year 
survival for uncemented THR in female patients aged < 60 
years was 82.3% (CI: 79.4–84.7) in Denmark, 81.3% (CI: 
77.8–84.3) in Sweden, 79.3% (CI: 76.8–81.5) in Norway, 
and 75.5% (CI: 73.4–77.5) in Finland. The 15-year survival 
for uncemented THR in male patients aged < 60 years was 
87.2% (CI: 84.8–89.2) in Denmark, 82.1% (CI: 78.5–85.2) in 
Table 2. Kaplan-Meier 10- and 15-year survival data with 95% CI for all THRs, 
cemented THR, uncemented THR, hybrid THR, and reverse hybrid THR by 
country. The 7.3-year survival of reverse hybrid THR in Denmark was 92.8% 
(95% CI: 90.3–94.7)
THR No. of No. of 10-year survival 15-year survival
   Country THRs revisions (%)     95% CI (%)     95% CI
All 
 Denmark 92,078 5,167 92.1 91.8–92.3 86.3 85.7–86.9
  Sweden 180,839 7,471 94.2 94.0–94.3 88.0 87.6–88.3
  Norway 86,076 4,656 92.8 92.6–93.1 86.9 86.4–87.4
  Finland 79,740 5,556 90.9 90.6–91.1 83.5 82.9–84.1
Cemented 
 Denmark 34,003 1,896 93.1 92.7–93.4 87.9 87.2–88.6
  Sweden 152,024 5,970 94.6 94.4–94.8 89.0 88.6–89.4
  Norway 60,957 3,171 93.4 93.1–93.6 88.8 88.2–89.3
  Finland 31,331 2,002 92.0 91.6–92.4 86.6 85.7–87.4
Uncemented 
 Denmark 37,098 1,734 92.4 91.9–92.9 86.0 84.5–87.3
  Sweden 13,552 582 91.7 90.8–92.6 82.7 80.5–84.7
  Norway 13,208 946 91.0 90.3–91.7 80.6 79.0–82.1
  Finland 38,082 2,742 90.0 89.5–90.4 80.8 79.9–81.8
Hybrid 
 Denmark 20,170 1,485 90.5 90.0–91.0 83.8 82.5–85.0
  Sweden 5,684 613 90.2 89.3–91.0 80.0 78.2–81.7
 Norway 2,827 274 90.6 89.2–91.8 82.2 79.6–84.4
 Finland 7,641 598 91.0 90.2–91.8 84.5 82.8–85.9
Reverse hybrid 
 Denmark 807 52 NA NA NA NA
  Sweden 9,579 306 91.8 90.0–93.3 NA NA
  Norway 9,084 265 92.9 91.2–94.2 NA NA
  Finland 2,686 214 87.4 85.4–89.2 NA NA
 
NA: not available.
Figure 5. Kaplan-Meier survival for all total hip replace-
ments in the NARA database (by country), with any 
reason for revision as endpoint.  
Figure 6. Kaplan-Meier survival for cemented total hip 
replacement in the NARA database (by country), with 
any reason for revision as endpoint.  
Figure 7. Kaplan-Meier survival for uncemented total hip 
replacement in the NARA database (by country), with 
any reason for revision as endpoint.  
Figure 8. Kaplan-Meier survival for hybrid total hip 
replacement (cemented cup, cementless stem) in the 
NARA database, by country, with any reason for revision 
as endpoint.  
Sweden, 78.0% (CI: 75.0–80.7) in Norway, and 80.1% (CI: 
78.1–81.9) in Finland. 
Revision risk for all THRs was statistically significantly less 
in Sweden than in all other countries during the first 5 years of 
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follow-up (Table 4 (see supplementary data) and 
Figure 10).
Revision risk for cemented THR was statisti-
cally significantly less in Sweden than in all other 
countries during the first 8 years of follow-up 
(Table 4 (see supplementary data) and Figure 11).
Regarding uncemented THR, the risk of revi-
Revision risk for uncemented THR in male patients aged 
less than 60 years was less in Denmark during the time period 
from 5 to 14 years after THR than in Sweden (Table 6, see sup-
plementary data). Revision risk for cemented THR in female 
patients aged less than 60 years was higher in Finland during 
the first 5 years and in male patients during the first 2 years 
after THR than in Sweden (Table 6, see supplementary data). 
Revision risk for cemented THR in women aged 60 years 
and over was higher in the 3 other countries than in Sweden 
during the first 8 years, except during the first half-year period 
Figure 9. Kaplan-Meier survival for reverse hybrid total 
hip replacement (uncemented cup, cemented stem) in 
the NARA database, by country, with any reason for revi-
sion as endpoint. 
Table 3. Kaplan-Meier 10- and 15-year survival data with 95% confidence inter-
vals from subgroup analyses performed separately for female and male patients 
aged < 60 years and ≥ 60 years and for cemented and uncemented THR, by coun-
try. The 9.7-year survival of uncemented THR in Sweden for female patients aged 
≥ 60 years was 91.4% (95% CI: 86.5–94.5) 
THR No. of No. of 10-year survival 15-year survival
   Country THRs revisions (%)     95% CI (%)     95% CI
Females < 60 years of age      
 Cemented THR 
 Denmark 1,139 128 89.1 86.7–91.0 81.5 77.8–84.6
  Sweden 8,882 691 92.2 91.5–92.9 83.0 81.5–84.4
  Norway 3,318 299 89.8 88.4–91.1 79.6 76.6–82.2
  Finland 847 99 88.2 85.4–90.6 NA NA
  Uncemented THR 
 Denmark 5,970 386 90.8 89.6–91.8 82.3 79.4–84.7
  Sweden 4,114 216 91.2 89.6–92.6 81.3 77.8–84.3
  Norway 3,842 355 90.6 89.3–91.7 79.3 76.8–81.5
  Finland 7,017 722 87.4 86.2–88.4 75.5 73.4–77.5
Males < 60 years of age              
  Cemented THR 
 Denmark 1,057 163 86.1 83.5–88.2 77.0 73.2–80.4
  Sweden 7,088 629 91.2 90.3–92.0 79.9 77.9–81.7
  Norway 1,990 189 88.4 86.4–90.1 80.1 76.3–83.4
  Finland 662 86 84.9 81.1–88.0 NA NA
  Uncemented THR 
 Denmark 6,815 346 93.0 92.1–93.9 87.2 84.8–89.2
  Sweden 4,678 221 92.0 90.5–93.3 82.1 78.5–85.2
  Norway 2,948 292 89.9 88.4–91.2 78.0 75.0–80.7
  Finland 7,083 631 89.3 88.3–90.2 80.1 78.1–81.9
Females ≥ 60 years of age              
  Cemented THR 
 Denmark 20,462 930 94.4 94.0–94.8 90.7 89.8–91.5
  Sweden 85,109 2,416 96.0 95.8–96.2 92.3 91.8–92.8
  Norway 39,844 1,612 95.0 94.7–95.2 91.8 91.2–92.3
  Finland 19,998 1,166 92.7 92.2–93.2 88.4 87.5–89.2
  Uncemented THR 
 Denmark 12,903 547 93.2 92.3–94.0 NA NA
  Sweden 2,148 61 NA NA NA NA
  Norway 4,111 175 93.3 92.0–94.4 87.2 83.9–90.0
  Finland 12,889 747 91.5 90.7–92.2 85.0 83.4–86.5
Males ≥ 60 years of age              
  Cemented THR 
 Denmark 11,345 675 92.2 91.5–92.8 86.4 84.9–87.7
  Sweden 50,945 2,234 93.5 93.2–93.8 87.7 86.9–88.4
  Norway 15,805 1,071 90.6 90.0–91.2 84.0 82.5–85.4
  Finland 9,824 651 91.5 90.7–92.2 84.5 82.6–86.1
  Uncemented THR 
 Denmark 11,410 455 93.1 92.1–94.0 NA NA
  Sweden 2,612 84 92.9 90.3–94.9 NA NA
  Norway 2,307 124 92.0 90.0–93.6 NA NA
  Finland 11,093 642 91.4 90.5–92.2 82.4 80.3–84.4
NA: not available.
Figure 10. Countrywise hazard ratio (HR) for risk of 
revision of all THRs compared to the reference country, 
Sweden (HR = 1). HRs are presented in 1-year time peri-
ods, except that the first year has been divided into 2 
periods. If there were less than 20 cases in the group, 
the HRs were not included in the graphs due to the inter-
vals being too wide. The model was stratified by sex, age 
group, and diagnosis.
sion was statistically significantly less in Denmark than in 
Sweden during the sixth year (HR = 0.53, CI: 0.34–0.82; p = 
0.005), the seventh year (HR = 0.60, CI: 0.37–0.97; p = 0.04), 
and the ninth year (HR = 0.59, CI: 0.36–0.98; p = 0.04) of 
follow-up (Table 4 (see supplementary data) and Figure 12).
Revision risk for hybrid THR was less during the first 5 years 
after THR in Sweden than in Denmark and Finland. Revision 
risk for reverse hybrid THR was less in Sweden during the 
time period from 0.5 to 8 years after THR than for the equiva-
lent period in Finland (Table 5, see supplementary data).
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in Norway (Table 7, see supplementary data). Revision risk 
for cemented THR in men aged 60 years and over was higher 
93.6–94.6 vs. 95.2%, CI: 94.7–95.7) and in Norway (95.0%, 
CI: 94.2–95.7 vs. 96.8%, CI: 96.1–97.4). 
Figure 12. Countrywise hazard ratio (HR) for risk of revision of unce-
mented THA compared to the reference country, Sweden (HR = 1). 
HRs are presented in 1-year time periods, except that the first year 
has been divided into 2 periods. If there were less than 20 cases in 
the group, the HRs were not included in the graphs due to the inter-
vals being too wide. The model was stratified by sex, age group, and 
diagnosis.
Figure 11. Countrywise hazard ratio (HR) for risk of revision of 
cemented THA compared to the reference country, Sweden (HR = 1). 
HRs are presented in 1-year time periods, except that the first year 
has been divided into 2 periods. If there were less than 20 cases in 
the group, the HRs were not included in the graphs due to the inter-
vals being too wide. The model was stratified by sex, age group, and 
diagnosis.
Figure 13. Kaplan-Meier survival analysis of cemented total hip replacement in 3 time periods with revi-
sion for any reason as the endpoint. A. Denmark. B. Norway. C. Sweden. D. Finland.  
  A
  C
  B
  D
in Finland and Norway during 
the first 8 years than in Sweden 
(Table 7, see supplementary 
data).
Results of time-trend analy-
sis of cemented and unce-
mented THR in Denmark, 
Norway, Sweden, and Fin-
land for the time periods 
1995–1999, 2000–2005, and 
2006–2011 are presented in 
Table 8 (see supplementary 
data) and in Figures 13 and 14. 
The 10-year survival of both 
cemented and uncemented 
implants was significantly 
higher in all countries for the 
time period 2000–2005 than 
for the time period 1995–1999. 
The 5-year survival of either 
cemented or uncemented 
implants, however, was not 
higher in any of the countries 
for the time period 2006–2011 
than for the time period 2000–
2005. The 5-year survival of 
uncemented implants was sta-
tistically significantly lower 
for the time period 2006–2011 
than for the time period 1995–
1999 in Finland (94.1%, CI: 
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Discussion
The differences in THR survival rates among Nordic countries 
were considerable. The inferior survival results in Finland are 
probably due to a high proportion of uncemented THRs with 
high amounts of liner wear revisions. Furthermore, increased 
use of uncemented implants in elderly patients increases the 
risk of early periprosthetic fractures. Overall revision risk for 
both cemented and uncemented THR was lower in Sweden 
than in the other countries. However, revision risk for unce-
mented THR was less in Denmark than that in Sweden towards 
the end of the follow-up, especially in male patients below 60 
years of age. These differences may reflect different choices of 
implant in the different countries. 
A major strength of our study was the unique collabora-
tion of 4 national registries to create a multinational database 
with large numbers of patients and a long follow-up time. 
The main weakness of the present study was that the mini-
mal NARA dataset includes only basic information common 
to all national registries. Our data did not include complete 
information on parameters such as bearing surface material, 
American Society of Anesthesiologists (ASA) grade, and 
was lowest in Finland, and the proportions of the 2 young-
est age groups were highest. The fact that overall, THRs are 
performed in younger patients in Finland than in the 3 other 
countries may in part explain the inferior implant survival in 
Finland. 
There has been a substantial decrease in the incidence of 
THR in patients with rheumatoid arthritis after 2001, due 
to more effective pharmacological treatment (Hekmat et al. 
2011). The proportion of patients with inflammatory arthritis 
has decreased in Denmark, Norway, and Sweden compared 
to our previous study—by about 1 percentage point in each 
country (Havelin et al. 2009). The proportion of patients with 
inflammatory arthritis was high in Finland. The incidence of 
inflammatory arthritis may be higher in Finland than in the 
other Nordic countries. 
The proportion of patients with hip fracture was lowest in 
Finland. There may be inconsistency between countries in 
recording of acute hip fractures, late failed osteosynthes, and 
posttraumatic osteoarthritis. In Finland, cases of failed osteo-
syntheses are not recorded separately but as other reasons 
for secondary osteoarthritis. Furthermore, in Finland acute 
hip fractures are often treated with hemiarthroplasty, which 
Figure 14. Kaplan-Meier survival analysis of uncemented total hip replacement in 3 time periods with 
revision for any reason as the endpoint. A. Denmark. B. Norway. C. Sweden. D. Finland.  
  A
  C
  B
  D
patient-reported outcome mea-
sures (PROMs). Bearing surface 
data might be an important con-
founder when studying differ-
ences in revision risk between 
countries. However, we believe 
that the high number of implants 
in our study makes the bear-
ing surface bias tolerable. Also, 
coding of diagnoses and reasons 
for revision are not the same in 
the 4 countries. One of the aims 
of the NARA collaboration is to 
standardize these issues. 
Demographics
The proportion of female 
patients is higher in Norway than 
in the other Nordic countries, as 
described earlier (Lohmander et 
al. 2006, Havelin et al. 2009). It 
has been suggested that the high 
proportion of women is associ-
ated with the high incidence of 
pediatric hip disease in Norway 
(Havelin et al. 2009). However, 
the proportion of male patients 
in Norway has increased by 2 
percentage points compared 
to our previous analysis (Hav-
elin et al. 2009). The propor-
tion of patients aged ≥ 75 years 
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may bias the results. Partial hip arthroplasty is not recorded 
separately in Finland and Denmark, unlike in Norway and in 
Sweden (Gjertsen et al. 2008, SHAR 2011). Hemiarthroplasty 
data were not included in our study. The relative number of 
hip fractures has increased in Denmark compared to our ear-
lier report. Hip fractures are also more common in Denmark 
than in Norway and Sweden (Havelin et al. 2009). This may 
be related to the increased amount of femoral neck fractures 
due to the aging population, or a tendency to treat more acute 
hemiarthroplasty with THR. 
The proportion of patients who were operated for pediatric 
hip diseases was highest in Norway, which supports our previ-
ous findings (Havelin et al. 2009). Childhood hip diseases may 
be more common in Norway than in other Nordic countries. 
On the other hand, diagnostics and treatment of childhood 
diseases may have been different in earlier days compared to 
Sweden and Denmark (Havelin et al. 2009). The proportion 
of pediatric hip diseases was lowest in Finland, whereas the 
proportion of “other reasons for secondary OA” was high-
est in Finland. In the Finnish data collection form, there is an 
option called secondary osteoarthritis. Some pediatric hips are 
probably coded under the heading of secondary osteoarthritis 
along with dysplastic hips. Thus, we believe that the category 
“other reasons” in the NARA database most probably includes 
some Finnish patients with dysplastic hips. There have been 
no remarkable changes concerning the proportion of pediatric 
hip disease diagnosis in any of the 3 countries (Havelin et al. 
2009).
The proportion of all THR diagnoses that are nontraumatic 
femoral head necrosis is low, and has remained the same in 
Denmark, Norway and Sweden (Havelin et al. 2009). The 
proportion of this diagnosis in Finland is lower than in other 
countries, which may be due to classification into “other rea-
sons for secondary osteoarthritis”. 
Implant fixation
The proportion of uncemented THRs was higher in Denmark 
and in Finland than in Sweden and Norway. The Swedish 
and Norwegian registries were established earlier than the 
Danish registry. The good results of cemented THR and the 
inferior results of some uncemented THR brands in Swed-
ish and Norwegian registries have encouraged the continued 
use of cemented THR in these countries (Havelin et al. 2009). 
During the last 5 years, the proportion of uncemented THRs 
has also increased in Norway and in Sweden. The proportion 
of all THRs that are cemented THR has decreased by 9 per-
centage points in Denmark, 5 percentage points in Sweden, 
and 8 percentage points in Norway compared to the previous 
report (Havelin et al. 2009). Hybrids were highly common in 
Denmark and relatively rare in Norway and in Sweden. How-
ever, the proportion of hybrids has decreased by about 4 per-
centage points in Denmark compared to the previous report 
(Havelin et al. 2009). Reverse hybrids are more popular in 
Norway and Sweden than in Denmark and Finland. The pro-
portion of reverse hybrids has increased in Norway compared 
to the previous NARA report (Havelin et al. 2009), probably 
due to good results with the concept being reported from the 
Norwegian national registry (Lindalen et al. 2011). 
 
Approach
The posterior approach is common in Denmark but it is rela-
tively rare in Norway. The relatively high number of revisions 
due to dislocation in Denmark may be associated with the 
posterior approach, as suggested earlier (Havelin et al. 2009). 
The proportion of posterior approach has remained unchanged 
in Denmark, Norway, and Sweden compared to our previ-
ous report (Havelin et al. 2009). In Finland, data on surgical 
approach have not been available.
Implant survival
The differences in survival rates for cemented THR among 
the Nordic countries were considerable. Revision risk for 
cemented THR was lowest in Sweden. The Swedish Hip 
Arthroplasty Register has provided feedback to the profes-
sion for more than 30 years. This appears to have led to the 
selection of implants with long documentation. Continued 
training and feedback to surgeons is important, not least for 
cemented implants. Revision risk for hybrid THR was higher 
in Denmark and Finland than in Sweden, probably reflecting 
cementing technique and implant choice considerations. Revi-
sion risk for reverse hybrid THR was higher in Finland than in 
Sweden, perhaps due to different implant selection.
Revision risk for uncemented THR was lower in Sweden 
than in Finland. This difference was also observed when Den-
mark was compared to Sweden, but only for the first years 
after the operation. With increasing follow–up, the survival of 
uncemented THRs improved in Denmark relative to Sweden 
and during the sixth, seventh, and ninth year of follow-up it 
became higher in Denmark. Revision risk was low in Den-
mark, especially in male patients less than 60 years of age. 
Implant choices and differences in bearing surface options 
may explain the relatively high degree of implant survival in 
Denmark. The use of highly crosslinked polyethylene liners 
may protect against liner wear and osteolysis. Unfortunately, 
complete bearing surface data are not available in the NARA 
dataset. In subgroup analyses of cemented and uncemented 
THR in female and male patients aged < 60 and ≥ 60 years, 
the revision risk in Finland was significantly higher than that 
in Sweden in every category. 
In time-trend analyses, the 10-year survival of both cemented 
and uncemented THRs was higher for the time period 2000–
2005 than for the time period 1995–1999 in all countries. We 
believe that the publication of registry studies pointing out 
inferior implants and cements has played an important role in 
this development. The 5-year survival of cemented or unce-
mented THRs, however, was not higher for the time period 
2006–2011 than for the time period 2000–2005 in any of the 
countries. It is worrisome that although the overall survival of 
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THRs in Nordic countries is high, the short-term survival of 
the most recent implants is no better, or it has become even 
worse than that of implants inserted in 2000–2005. The poor 
short-term results for the most recent uncemented THRs in 
Finland and Norway may be due to changes in the implant 
choices and the use of uncemented implants in older patients. 
These data were unadjusted, and the increased use of unce-
mented implants in elderly patients may perhaps explain our 
findings. However, the overall adjusted revision rate for unce-
mented THR was also higher in a relatively recent study based 
on the Norwegian Arthroplasty Register data from the most 
recent study period (2003–2007) than in 1998–2002 (Fevang 
et al. 2010). Furthermore, elderly patients with uncemented 
implants may have more infections (Dale et al. 2012). 
Thoretically, the threshold for reporting revisions may vary 
between countries, which would obviously influence survival 
results. There may also be differences in revision indications 
between countries. The operative volume of individual sur-
geons is not known and may bias the results. Uncemented 
large-diameter head metal-on-metal THR has been used 
mainly in Denmark and Finland, not in Norway and rarely 
in Sweden. The results with most large-diameter head metal-
on-metal implants have been poor, due to the relatively high 
incidence of adverse reactions to metal debris (Ollivere et al. 
2009, AOA 2010, Johanson et al. 2010, Langton et al. 2010, 
NJR 2011). It is possible that the revision rate for cementless 
THR will increase in the future in Denmark and Finland due to 
revision of large-diameter head metal-on-metal THRs. 
Revisions
The proportion of periprosthetic fractures that led to revision 
was the same in Denmark, Sweden, and Finland (8%). In 
Norway, the proportion of revisions performed due to peri-
prosthetic fracture was lower (only 4%). The use of cemented 
implants in Norway may have prevented early periprosthetic 
fractures. The proportion of periprosthetic fractures that were 
a reason for revision has increased in Sweden and Denmark—
but not in Norway—compared to the previous report, which 
may be related to the increased use of uncemented implants.
The proportion of revisions due to infection is similar in 
Sweden, Norway, and Denmark, whereas in Finland it appears 
to be less frequent. However, NARA data are biased because 
they only include revision with change of implant parts, such 
as liner or head, and debridements without any change of liner 
or head are not included. It has been stated that the low rate of 
infected knee replacements in the Finnish Arthroplasty Regis-
ter is an underestimate (Jämsen et al. 2009). 
Aseptic loosening is the most common reason for revision 
in all 4 countries. The proportion of revisions for aseptic loos-
ening related to the total numbers was found to be at the same 
level in Sweden, Norway, and Denmark as it was in the pre-
vious report (Havelin et al. 2009). The proportion of aseptic 
loosening is low in Denmark compared to the other countries, 
including Finland. The proportion of revisions performed for 
pain only is as low in Sweden as it was previously compared 
to Norway and Denmark (Havelin et al. 2009). Revisions per-
formed for pain only are not recorded in the Finnish regis-
try. The proportion of revisions performed for other reasons 
is high in Finland. The outdated Finnish data collection form 
may explain this deficiency.
In Denmark and Norway, the surgical procedure performed 
at the revision was most often replacement of the cup or liner. 
In addition to loosening, this may be caused by polyethylene 
wear of uncemented cups—especially in Denmark, with its 
long-standing tradition of using uncemented THR. In Sweden, 
total revisions of both stem and cup were as common as cup 
revisions only. The proportion of cup or liner revisions has 
increased in Sweden and Norway compared to the previous 
report, probably due to the increased amounts of cementless 
implants (Havelin et al. 2009). In Denmark, the proportion of 
cup and liner revisions has remained the same. The propor-
tion of stem revisions is similar in Denmark, Norway, and 
Sweden. Most cases recorded as extraction of the prosthesis 
are probably first-stage revision procedures of 2-stage infec-
tion revisions. They might serve as indicators of those deep-
infection revisions that are treated in 2 stages as opposed 
to those treated in 1 stage or with lavage and debridement 
only. However, this has not been validated. The proportions 
of all procedures that involved extraction of the prosthesis 
have decreased in Norway and Sweden by 1 and 3 percentage 
points, respectively, compared to the previous data (Havelin 
et al. 2009). 
Conclusions
The differences in THR survival rates between the 4 Nordic 
countries studied were considerable. Overall revision risk for 
THR was less in Sweden than in the other countries. However, 
revision risk for uncemented THR was less in Denmark than 
in Sweden for implants with longer follow-up periods corre-
sponding to the sixth, seventh, and ninth year of follow-up. 
This may reflect differences between implant choices, an issue 
that requires detailed studies of the specific THR brands used 
in these 4 Nordic countries. 
Supplementary data
Tables 4-8 are available at Acta’s website (www.actaorthop.
org), identification number 6792.
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